Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.79 |
| ▸ | ACE | P12821 | 3/20 | 0.73 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.70 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.70 |
| ▸ | ITGAL | P20701 | 3/20 | 0.70 |
| ▸ | TACR1 | P25103 | 1/20 | 0.69 |
| ▸ | ECE1 | P42892 | 6/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | APAF1 | O14727 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | FPR2 | P25090 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetyltryptophan SCHEMBL4216452 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL29360698 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL702442 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL57140 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL4216450 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL57141 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL23933298 | 0.99 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL1427071 | 0.99 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL1304487 | 0.99 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL11471934 | 0.99 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724459-A1 | PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | Peptidream Inc (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-12534439-B2 | Xanthohumol derivatives and methods for making and using | OREGON STATE UNIVERSITY (US) | 2026-01-27 | — | — | US | disclosed |
| EP-4667480-A1 | TRANSLATION INITIATION WITH EXOTIC AMINO ACIDS USING EF-P-RESPONSIVE ARTIFICIAL INITIATOR TRNA | The University of Tokyo (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-20250298025-A1 | METHODS FOR THE DETECTION AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2025-09-25 | — | — | US | disclosed |
| US-20250138016-A1 | METHODS FOR THE DETECTION AND TREATMENT OF OVARIAN CANCER | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2025-05-01 | — | — | US | disclosed |
| WO-2025032220-A1 | LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF | MERZ PHARMA GMBH & CO. KGAA (DE) | 2025-02-13 | — | — | WO | disclosed |
| WO-2024252336-A1 | PEPTIDE COMPOSITIONS TARGETING GLYPICAN-3 AND USES THEREOF | PEPTIDREAM INC. (JP) | 2024-12-12 | — | — | WO | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| EP-4421082-A1 | POLYPEPTIDE AND APPLICATION THEREOF AS CCK RECEPTOR AGONIST/ANTAGONIST | Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences Limited (HK) | 2024-08-28 | — | — | EP | disclosed |
| WO-2024172058-A1 | TRANSLATION INITIATION WITH EXOTIC AMINO ACIDS USING EF-P-RESPONSIVE ARTIFICIAL INITIATOR tRNA | 国立大学法人東京大学 | 2024-08-22 | — | — | WO | disclosed |
| US-11970694-B2 | Rapid display method in translational synthesis of peptide | PEPTIDREAM INC. (JP) | 2024-04-30 | — | — | US | disclosed |
| US-20240051922-A1 | XANTHOHUMOL DERIVATIVES AND METHODS FOR MAKING AND USING | OREGON STATE UNIVERSITY (US) | 2024-02-15 | — | — | US | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| US-20230324394-A1 | METHODS FOR THE DETECTION AND TREATMENT OF PANCREATIC DUCTAL ADENOCARCINOMA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2023-10-12 | — | — | US | disclosed |
| CN-116694480-A | Dark She Kongjun S-LWZ20190428-3 and application thereof in preparation of rice fungus grains | 中国科学院微生物研究所 | 2023-09-05 | — | — | CN | disclosed |
| CN-116445299-A | Phellinus linteus S-LWZ20210623-1a and application thereof in preparation of rice fungus grains | 中国科学院微生物研究所 | 2023-07-18 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| EP-4031557-A1 | METHODS FOR PRODUCING D-TRYPTOPHAN AND SUBSTITUTED D-TRYPTOPHANS | The Regents of the University of California (US) | 2022-07-27 | — | — | EP | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534439-B2 | Xanthohumol derivatives and methods for making and using | MT-CO1, MT-CO2, PC | ALOX15 3449/4885ACE 4473/4885ITGB2 4054/4885 |
| US-20240051922-A1 | XANTHOHUMOL DERIVATIVES AND METHODS FOR MAKING AND USING | XDH, PC, TFB2M | ALOX15 1777/4885ACE 3688/4885ITGB2 4853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.